Personalized bio-engineered tissue therapy to transform skin surgery
We are a Swiss emerging company focusing on innovation in regenerative medicine. Our first focus is to provide patients who suffer from large skin injuries and defects with personalized skin tissue therapy in a safe, effective and accessible manner.
CUTISS manufactures its lead product for clinical use
in its state of the art, certified Good Manufacturing Practice Facility
in Schlieren near Zurich.
CUTISS has developed first-in-class machine for the automated production of tissue therapy. To secure scale-up, allow decentralization and achieve relevant cost reduction for the manufacturing of denovoSkin, CUTISS has been developing first-in-class automated bio-reactors with leading Swiss and international engineering partners. This pioneering, proprietary platform may also be used beyond skin for the next-priority human tissues (muscle, gums, etc.) in the future.